keyword
https://read.qxmd.com/read/38673824/the-complex-relationship-between-mechanisms-underlying-inflammatory-bowel-disease-its-treatment-and-the-risk-of-lymphomas-a-comprehensive-review
#21
REVIEW
Katarzyna Stasik, Rafał Filip
Patients with inflammatory bowel disease may be at higher risk of developing lymphomas and other cancers of the gastrointestinal tract. In addition, there may be a link between the use of thiopurines or anti-tumor necrosis factor drugs (anti-TNF) and these pathologies. The treatment of patients with Crohn's disease who have previously been diagnosed with lymphoma is a challenge for gastroenterologists. In this report, we examine important clinical issues related to the treatment of patients with inflammatory bowel disease with active lymphoma, as well as of patients with hematological cancer history...
April 11, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38673573/management-of-post-operative-crohn-s-disease-knowns-and-unknowns
#22
REVIEW
Matteo Spertino, Roberto Gabbiadini, Arianna Dal Buono, Anita Busacca, Gianluca Franchellucci, Giulia Migliorisi, Alessandro Repici, Antonino Spinelli, Cristina Bezzio, Alessandro Armuzzi
Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract characterized by relapsing-remission phases. CD often requires surgical intervention during its course, mainly ileo-cecal/ileo-colonic resection. However, surgery in CD is not curative and post-operative recurrence (POR) can happen. The management of CD after surgery presents challenges. Ensuring timely, effective, and safe therapy to prevent POR is essential but difficult, considering that approximately 20-30% of subjects may not experience endoscopic POR and that 40-50% will only exhibit intermediate lesions, which carry a low risk of mid- and long-term clinical and surgical POR...
April 16, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38671346/adequate-antiviral-treatment-lowers-overall-complications-of-cytomegalovirus-colitis-among-inpatients-with-inflammatory-bowel-diseases
#23
JOURNAL ARTICLE
Ching-Reigh Hsieh, Ren-Chin Wu, Chia-Jung Kuo, Pai-Jui Yeh, Yuan-Ming Yeh, Chyi-Liang Chen, Cheng-Tang Chiu, Cheng-Hsun Chiu, Yu-Bin Pan, Yung-Kuan Tsou, Puo-Hsien Le
BACKGROUND: Cytomegalovirus (CMV) colitis significantly complicates the course of inflammatory bowel disease (IBD), frequently leading to severe flare-ups and poor outcomes. The role of antiviral therapy in hospitalized IBD patients with CMV colitis is currently under debate. This retrospective analysis seeks to clarify the influence of antiviral treatment on these patients. METHODS: We retrospectively reviewed IBD patients diagnosed with CMV colitis via immunohistochemistry staining from colonic biopsies at a major tertiary center from January 2000 to May 2021...
April 26, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38667916/-candida-tropicalis-affects-candida-albicans-virulence-by-limiting-its-capacity-to-adhere-to-the-host-intestinal-surface-leading-to-decreased-susceptibility-to-colitis-in-mice
#24
JOURNAL ARTICLE
Kyle Roberts, Abdullah Osme, Carlo De Salvo, Eleonora Zoli, Janet Herrada, Thomas S McCormick, Mahmoud Ghannoum, Fabio Cominelli, Luca Di Martino
Candida ( C. ) infections represent a serious health risk for people affected by inflammatory bowel disease. An important fungal virulence factor is the capacity of the fungus to form biofilms on the colonized surface of the host. This research study aimed to determine the effect of a C. tropicalis and C. albicans co-infection on dextran sodium sulfate (DSS)-induced colitis in mice. The colitis severity was evaluated using histology and a colonoscopy. The mice were mono-inoculated with C. albicans or C. tropicalis or co-challenged with both species...
March 25, 2024: Journal of Fungi (Basel, Switzerland)
https://read.qxmd.com/read/38666993/perioperative-considerations-for-the-surgical-treatment-of-crohn-s-disease-with-discussion-on-surgical-antibiotics-practices-and-impact-on-the-gut-microbiome
#25
REVIEW
Shelbi Olson, Lindsay Welton, Cyrus Jahansouz
Crohn's disease, a chronic inflammatory process of the gastrointestinal tract defined by flares and periods of remission, is increasing in incidence. Despite advances in multimodal medical therapy, disease progression often necessitates multiple operations with high morbidity. The inability to treat Crohn's disease successfully is likely in part because the etiopathogenesis is not completely understood; however, recent research suggests the gut microbiome plays a critical role. How traditional perioperative management, including bowel preparation and preoperative antibiotics, further changes the microbiome and affects outcomes is not well described, especially in Crohn's patients, who are unique given their immunosuppression and baseline dysbiosis...
March 30, 2024: Antibiotics
https://read.qxmd.com/read/38665796/creation-of-an-institutional-preoperative-checklist-to-support-clinical-risk-assessment-in-patients-with-ulcerative-colitis-uc-considering-ileoanal-pouch-surgery
#26
JOURNAL ARTICLE
Bruno Augusto Alves Martins, Amira Shamsiddinova, Manal Mubarak Alquaimi, Guy Worley, Phil Tozer, Kapil Sahnan, Zarah Perry-Woodford, Ailsa Hart, Naila Arebi, Manmeet Matharoo, Janindra Warusavitarne, Omar Faiz
BACKGROUND: Total proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the most established restorative operative approach for patients with ulcerative colitis. It has associated morbidity and the potential for major repercussions on quality of life. As such, patient selection is crucial to its success. The main aim of this paper is to present an institutional preoperative checklist to support clinical risk assessment and patient selection in those considering IPAA. METHODS: A literature review was performed to identify the risk factors associated with surgical complications, decreased functional outcomes/quality of life, and pouch failure after IPAA...
May 2024: Frontline Gastroenterology
https://read.qxmd.com/read/38665795/role-of-diet-in-prevention-versus-treatment-of-crohn-s-disease-and-ulcerative-colitis
#27
REVIEW
Emma P Halmos, Lihi Godny, Julie Vanderstappen, Chen Sarbagili-Shabat, Vaios Svolos
Diet is a modifiable risk factor for disease course and data over the past decade have emerged to indicate its role in Crohn's disease (CD) and ulcerative colitis (UC). However, literature is riddled with misinterpretation of data, often leading to unexpected or conflicting results. The key understanding is that causative factors in disease development do not always proceed to an opportunity to change disease course, once established. Here, we discuss the data on dietary influences in three distinct disease states for CD and UC-predisease, active disease and quiescent disease...
May 2024: Frontline Gastroenterology
https://read.qxmd.com/read/38665135/c-reactive-protein-an-inflammatory-biomarker-and-a-predictor-of-neurodegenerative-disease-in-patients-with-inflammatory-bowel-disease
#28
REVIEW
Simona Muresan, Mark Slevin
Inflammatory bowel disease (IBD) refers to two chronic conditions of the digestive tract: ulcerative colitis (UC) and Crohn's disease (CD), representing a progressive inflammatory process that mainly occurs in the gut, with frequent extra-intestinal manifestations. Even if remission is periodically obtained for some patients, the histological activity and digestive symptoms may continue, maintaining a persistent systemic inflammation that could induce further extra-intestinal complications and contribute to the development of neurodegenerative disease...
April 2024: Curēus
https://read.qxmd.com/read/38661931/the-need-for-surgery-in-pediatric-patients-with-inflammatory-bowel-disease-treated-with-biologicals
#29
JOURNAL ARTICLE
Kaija-Leena Kolho, Anne Nikkonen, Laura Merras-Salmio, Pauliina Molander
PURPOSE: Inflammatory bowel disease (IBD) in childhood often presents with a more extensive and more aggressive disease course than adult-onset disease. We aimed to evaluate if biological treatment started in childhood decreases the need for intestinal surgery over time. METHODS: This was a retrospective, single-center, cohort study. All pediatric patients with IBD initiated to biological therapy at the Children's Hospital, were included in the study and followed up to the first surgical procedure or re-operation in their adulthood or until 31...
April 25, 2024: International Journal of Colorectal Disease
https://read.qxmd.com/read/38660068/discontinuation-of-therapy-in-inflammatory-bowel-disease-current-views
#30
REVIEW
Antonio Meštrović, Marko Kumric, Josko Bozic
The timely introduction and adjustment of the appropriate drug in accordance with previously well-defined treatment goals is the foundation of the approach in the treatment of inflammatory bowel disease (IBD). The therapeutic approach is still evolving in terms of the mechanism of action but also in terms of the possibility of maintaining remission. In patients with achieved long-term remission, the question of de-escalation or discontinuation of therapy arises, considering the possible side effects and economic burden of long-term therapy...
April 6, 2024: World Journal of Clinical Cases
https://read.qxmd.com/read/38658864/analysis-and-prediction-of-nutritional-outcome-of-patients-with-pediatric-inflammatory-bowel-disease-from-bahrain
#31
JOURNAL ARTICLE
Hasan M Isa, Masooma Mohamed, Ahmed Alsaei, Zahra Isa, Enjy Khedr, Afaf Mohamed, Haitham Jahrami
BACKGROUND: Inflammatory bowel disease (IBD) is a chronic gastrointestinal disease that causes anorexia, malabsorption, and increased energy requirements. Childhood IBD can significantly impact nutritional status and future health. OBJECTIVE: This study aimed to analyze the nutritional status of patients with pediatric IBD at presentation and during follow-up and to identify predictors of nutritional outcome. METHODS: This retrospective cohort study reviewed the medical records of children diagnosed with IBD in the Pediatric Department, Salmaniya Medical Complex, Bahrain, 1984 - 2023...
April 24, 2024: BMC Pediatrics
https://read.qxmd.com/read/38655866/efficacy-of-dose-escalation-of-oral-5-aminosalicylic-acid-for-ulcerative-colitis-with-a-mayo-endoscopic-subscore-of-1-an-open-label-randomized-controlled-trial
#32
JOURNAL ARTICLE
Tomohiro Fukuda, Yasuhiro Aoki, Hiroki Kiyohara, Ayumi Yokoyama, Atsushi Nakazawa, Yusuke Yoshimatsu, Shinya Sugimoto, Kosaku Nanki, Yohei Mikami, Kayoko Fukuhara, Shinta Mizuno, Tomohisa Sujino, Makoto Mutaguchi, Kaoru Takabayashi, Yuichi Morohoshi, Yasuo Hosoda, Haruhiko Ogata, Yasushi Iwao, Makoto Naganuma, Takanori Kanai
BACKGROUND: Endoscopic healing is generally defined as Mayo endoscopic subscore (MES) ≤1 in ulcerative colitis (UC). However, patients with an MES of 1 are at higher relapse risk than those with an MES of 0. This study evaluated the therapeutic efficacy of proactive dose escalation of oral 5-aminosalicylic acid (5-ASA) in UC patients with an MES of 1. METHODS: An open-label, randomized controlled trial was conducted in 5 hospitals between 2018 and 2022. Ulcerative colitis patients in clinical remission under oral 5-ASA therapy and diagnosed as having an MES of 1 were enrolled...
April 24, 2024: Inflammatory Bowel Diseases
https://read.qxmd.com/read/38655181/antibiotics-influence-the-risk-of-anti-drug-antibody-formation-during-anti-tnf-therapy-in-chinese-inflammatory-bowel-disease-patients
#33
JOURNAL ARTICLE
Meng Sun, Jingyi Ju, Hongzhen Xu, Mengqi Luo, Zhaoyang Li, Yufang Wang
Aims: The formation of anti-drug antibodies (ADAs) during anti-tumor necrosis factor (anti-TNF) therapy is reported to lead to reducing serum drug levels, which may bring about a loss of response to treatment. Previous research has suggested an association between specific antibiotic classes and ADA formation during anti-TNF therapy. However, there are few studies specifically examining this association in Chinese inflammatory bowel disease (IBD) patients. Therefore, our study aimed to evaluate the possible effect of antibiotic use on ADA formation to anti-TNF therapy in Chinese patients with IBD...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38651743/predictors-of-irritable-bowel-syndrome-like-symptoms-in-quiescent-inflammatory-bowel-disease
#34
JOURNAL ARTICLE
Mehwish Ahmed, Autumn Pu, Kara Jencks, Shrinivas Bishu, Peter Higgins, William D Chey, Krishna Rao, Allen Lee
BACKGROUND: Many patients with quiescent inflammatory bowel disease (IBD) suffer from irritable bowel syndrome (IBS)-like symptoms. Although these symptoms cause significant reductions in quality of life, evidence-based treatments are lacking as risk factors and pathophysiology of these symptoms are not clearly defined. We aimed to identify risk factors for development of IBS-like symptoms in IBD patients with quiescent disease. METHODS: We performed a single-center retrospective cohort study of adults with IBD from 2015 to 2021...
April 23, 2024: Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society
https://read.qxmd.com/read/38651614/risk-factors-for-surgery-in-stricturing-small-bowel-crohn-s-disease-a-retrospective-cohort-study-from-the-getaid-p%C3%A3-diatrique
#35
JOURNAL ARTICLE
Edouard Lacotte, Louis Boujonnier, Christine Martinez-Vinson, Jérôme Viala, Delphine Ley, Stéphanie Coopman, Héloïse Lerisson, Alain Dabadie, Clémentine Dumant-Forrest, Bénédicte Pigneur, Frank Ruemmele, Raphael Enaud, Aurélie Comte, Julie Rebeuh, Valérie Bertrand, Nicolas Caron, Anne Breton, Rémi Duclaux-Loras, Ioana Vasies, Claire Dupont-Lucas
OBJECTIVES: Previous studies have shown rates of surgical resection of up to 41% in stricturing pediatric Crohn's disease. In this retrospective multicenter study, our aims were to identify clinical risk factors and magnetic resonance enterography (MRE) features of small bowel strictures associated with surgery. METHODS: Pediatric patients with symptomatic stricturing small bowel CD (defined as obstructive symptoms or proximal dilatation on MRE) confirmed by MRE between 2010 and 2020 were recruited from 12 French tertiary hospitals...
April 23, 2024: Journal of Pediatric Gastroenterology and Nutrition
https://read.qxmd.com/read/38650627/sishen-pill-and-its-active-phytochemicals-in-treating-inflammatory-bowel-disease-and-colon-cancer-an-overview
#36
REVIEW
Boxun Zhang, Yingying Cheng, Qin Jian, Sirui Xiang, Qi Xu, Chuchu Wang, Chuan Yang, Junzhi Lin, Chuan Zheng
The incidence of inflammatory bowel disease (IBD) and the associated risk of colon cancer are increasing globally. Traditional Chinese medicine (TCM) treatment has unique advantages. The Sishen Pill, a common Chinese patented drug used to treat abdominal pain and diarrhea, consists mainly of Psoraleae Fructus, Myristicae Semen, Euodiae Fructus, and Schisandra Chinensis. Modern research has confirmed that Sishen Pill and its active secondary metabolites, such as psoralen, myristicin, evodiamine, and schisandrin, can improve intestinal inflammation and exert antitumor pharmacological effects...
2024: Frontiers in Pharmacology
https://read.qxmd.com/read/38648666/best-practice-for-therapeutic-drug-monitoring-of-infliximab-position-statement-from-the-international-association-of-therapeutic-drug-monitoring-and-clinical-toxicology
#37
JOURNAL ARTICLE
Dahham Alsoud, Dirk Jan A R Moes, Zhigang Wang, Rani Soenen, Zohra Layegh, Murray Barclay, Tomoyuki Mizuno, Iris K Minichmayr, Ron J Keizer, Sebastian G Wicha, Gertjan Wolbink, Jo Lambert, Séverine Vermeire, Annick de Vries, Konstantinos Papamichael, Núria Padullés-Zamora, Erwin Dreesen
BACKGROUND: Infliximab, an anti-tumor necrosis factor monoclonal antibody, has revolutionized the pharmacological management of immune-mediated inflammatory diseases (IMIDs). This position statement critically reviews and examines existing data on therapeutic drug monitoring (TDM) of infliximab in patients with IMIDs. It provides a practical guide on implementing TDM in current clinical practices and outlines priority areas for future research. METHODS: The endorsing TDM of Biologics and Pharmacometrics Committees of the International Association of TDM and Clinical Toxicology collaborated to create this position statement...
April 17, 2024: Therapeutic Drug Monitoring
https://read.qxmd.com/read/38646813/severe-venous-calcifications-in-phlebosclerotic-colitis-and-significantly-decreased-expression-in-betaine
#38
JOURNAL ARTICLE
Xue Deng, Xuefeng Tang, Hui Yao, Ying Wang
Phlebosclerotic colitis (PC) is a rare type of chronic ischemic colitis. Its etiology is still unknown, and PC is also known as idiopathic mesenteric phlebosclerosis colitis. Currently, many studies have reported that long-term use of Chinese herbal medicine and drinking history are related to its pathogenesis. In the early stage of the lesion, due to insufficient understanding of PC, it is difficult to distinguish it from inflammatory bowel disease and other nonneoplastic intestinal diseases. We reported a case of severe diffuse total colon calcification with multiple misdiagnosis, summarizing and analyzing the clinical pathological characteristics to increase clinical and pathological physicians' understanding of the disease and reduce misdiagnosis...
April 22, 2024: International Journal of Surgical Pathology
https://read.qxmd.com/read/38646499/advances-in-molecular-mechanisms-of-inflammatory-bowel-disease%C3%A2-associated-colorectal-cancer-review
#39
REVIEW
Zhi Wang, Yu Chang, Haibo Sun, Yuqin Li, Tongyu Tang
The link between inflammation and cancer is well documented and colonic inflammation caused by inflammatory bowel disease (IBD) is thought to be a high-risk factor for the development of colorectal cancer (CRC). The complex crosstalk between epithelial and inflammatory cells is thought to underlie the progression from inflammation to cancer. The present review collates and summarises recent advances in the understanding of the pathogenesis of IBD-associated CRC (IBD-CRC), including the oncogenic mechanisms of the main inflammatory signalling pathways and genetic alterations induced by oxidative stress during colonic inflammation, and discusses the crosstalk between the tumour microenvironment, intestinal flora and host immune factors during inflammatory oncogenesis in colitis-associated CRC...
June 2024: Oncology Letters
https://read.qxmd.com/read/38643975/association-between-dietary-inflammation-index-and-inflammatory-bowel-disease-in-adults-results-from-national-health-and-nutrition-examination-survey-2009-2010
#40
JOURNAL ARTICLE
Jing-Yi Zhu, Xiao-Ru Sun, Mu-Yun Liu, Chang Sun
Previous study has demonstrated that the Dietary Inflammation Index (DII) played a role in the risk of inflammatory bowel disease (IBD), however, the prevalence and risk factors for IBD are distinct across locations and groups, and therefore, the findings are debatable and warrant further investigation. A total of 4363 participants were calculated in the National Health and Nutrition Examination Survey (NHANES) 2009 to 2010, of whom 1.21% self-reported a history of IBD. DII values were performed as a good predictor of dietary inflammation based on data from two 24-h dietary reviews in the NHANES database...
June 2024: Clinical and Experimental Pharmacology & Physiology
keyword
keyword
82250
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.